IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Kite Pharma, Inc.
Symbol: KITE
Price: Last trade $74.85
Trade Date: 12/10
Shares: 3.34 million
Underwriter(s) Jefferies, Citigroup, Cowen & Co., RBC Capital Markets
Co Manager(s) Stifel
Rating=Subscription Needed
Company: Accelerate Diagnotics, Inc.
Symbol: AXDX
Price: Last trade $17.99
Trade Date: 12/10
Shares: 4.4 million
Underwriter(s) J.P. Morgan, Piper Jaffray
Co Manager(s) William Blair & Co., BTIG
Rating=Subscription Needed
Company: CyrusOne Inc.
Symbol: CONE
Price: $36.00
Trade Date: 12/9
Shares: 1.35 million
Underwriter(s) Citigroup
Rating=Subscription Needed
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish